Home › Funds › Generali Investments CEE, investicni spolecnost, a.s. › BIIB
Generali Investments CEE, investicni spolecnost, a.s. position in BIIB
BIOGEN INC · Health Care
Generali Investments CEE, investicni spolecnost, a.s. reported holding 43,552 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$9.4M, representing 0.69% of its reported portfolio and ranking #36 among its reported holdings. Generali Investments CEE, investicni spolecnost, a.s. has disclosed BIIB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Generali Investments CEE, investicni spolecnost, a.s.'s BIIB position evolved
Generali Investments CEE, investicni spolecnost, a.s. first disclosed a stake in BIIB in Q4 2024 at 27,060 shares (US$4.1M). The position peaked in Q2 2026 at 43,552 shares, worth US$9.4M. Across 8 filings, Generali Investments CEE, investicni spolecnost, a.s. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 43,552 shares valued at US$9.4M. Notable position changes include a 43% increase in Q2 2025 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 27.06K | $4.14M | New |
| Q1 2025 | 27.06K | $3.70M | Hold |
| Q2 2025 | 38.76K | $4.87M | Add |
| Q3 2025 | 38.76K | $5.43M | Hold |
| Q4 2025 | 43.55K | $7.66M | Add |
| Q1 2026 | 43.55K | $7.98M | Hold |
| Q2 2026 | 43.55K | $9.41M | Hold |
| Q3 2026 | 43.55K | $9.41M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIIB and 13F data
BIIB (BIOGEN INC) is a Health Care company. 22 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIIB
- PRIMECAP MANAGEMENT CO/CA/ 15.15M sh · $3.27B · Q2 2026
More on Generali Investments CEE, investicni spolecnost, a.s.
FAQ
How long has Generali Investments CEE, investicni spolecnost, a.s. held BIIB?
Generali Investments CEE, investicni spolecnost, a.s. has disclosed BIIB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Generali Investments CEE, investicni spolecnost, a.s.'s current position in BIIB?
As of Q3 2026, Generali Investments CEE, investicni spolecnost, a.s. holds 43.55K shares of BIIB (BIOGEN INC), valued at $9.41M, representing 0.69% of its reported portfolio and ranking #36.
Has Generali Investments CEE, investicni spolecnost, a.s. been buying or selling BIIB?
In the latest 13F filing (Q3 2026), Generali Investments CEE, investicni spolecnost, a.s. held unchanged its position in BIIB. The position peaked in Q2 2026 at 43.55K shares.
Which other funds hold BIIB?
Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.